Source:http://linkedlifedata.com/resource/pubmed/id/11221756
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2001-2-8
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
1351-5101
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
7
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
750-1
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:11221756-Antiparkinson Agents,
pubmed-meshheading:11221756-Humans,
pubmed-meshheading:11221756-Journalism,
pubmed-meshheading:11221756-Newspapers,
pubmed-meshheading:11221756-Parkinson Disease,
pubmed-meshheading:11221756-Periodicals as Topic,
pubmed-meshheading:11221756-Public Relations,
pubmed-meshheading:11221756-Research
|
| pubmed:year |
2000
|
| pubmed:articleTitle |
Disseminating information about new therapies for Parkinson's disease: misunderstanding or misconduct?
|
| pubmed:publicationType |
Letter,
Comment
|